Providence Swedish
T

How I Optimize Biologic Therapies in IBD

By Providence Swedish FEATURING Timothy L. Zisman
By Providence Swedish FEATURING Timothy L. Zisman
573 views
August 1, 2024
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
20:02
Cedars Sinai

Monitoring Patients on IBD Therapies: How to Monitor? What Is the Im…

Feat. C. Ha
28:07
UChicago Medicine

Guidelines for Ulcerative Colitis Diagnosis and Management

Feat. D. T. Rubin
38:58
Northwestern Medicine Gastroenterology

Top Ten Advances in IBD 2023

Feat. S. Hanauer
26:16
Asher Kornbluth

Positioning Therapies in IBD (audio only)

29:48
Rubin Lab

Advanced UC Drugs & Positioning - November 2023, IBD School (Syd…

Feat. D. T. Rubin
21:56
MetroHealth

Positioning of Biologics and Small Molecules in Ulcerative Colitis

Feat. M. Landsman
23:23
Washington University in St. Louis

Positioning Medical Therapy in IBD

Feat. M. Ciorba
31:48
University of Colorado Department of Medicine

Optimizing Current IBD Therapies

Feat. M. Long
32:09
MedStar Georgetown and Northwestern University IBD Masterclass

Goals of Treatment in IBD: Treatment Endpoints and Putting Risks int…

Feat. C. Siegel
22:51
MetroHealth

Management of Pouchitis and Its Complications

Feat. B. Shen
21:04
DDW 2023 Conference Coverage

DDW 2023 Updates and Perspectives: Evolution in Medical Treatments f…

Feat. S. Hanauer
32:09
University of Colorado Department of Medicine

New and Emerging Treatments for IBD in 2024

Feat. M. Chiorean
67:28
Rubin Lab

State of the Art Management of IBD: How Should We Sequence Therapies…

Feat. D. T. Rubin
36:00
Providence Swedish

How I Optimize Small Molecules in IBD

Feat. M. Chiorean
33:16
NYU Langone

Precision Medicine in IBD

Feat. M. Long
14:53
Gil Melmed

IL12/23 and IL23 Selective Inhibition in Inflammatory Bowel Disease

23:40
University of Colorado Department of Medicine

New and Emerging Therapies for Inflammatory Bowel Disease

Feat. W. Ahmed
18:26
Washington University in St. Louis

Leukocyte Trafficking Agents in the Management of IBD

Feat. K. Huff-Hardy
21:18
EBMed

Debate: Stride II: Should We Treat to Target or Treat to Symptom Res…

Feat. B. Abraham, A. Charabaty
19:42
Columbia University

Rethinking Current and Future Treatment Sequence of Moderate to Seve…

Feat. E. Scherl